Eden Research Share Discussion Threads

[northwick] 26/1/2021 11:18

Surprised to see the share price jump up on very little volume. Now-14.2-14.5Either MM are short of stock or are we close to some exciting news. A new shareholder seems to think we will hear news shortly.

[alchemy] 26/1/2021 11:05

Many thanks

[alchemy] 26/1/2021 11:04

Ok in , in a small way .Now tell me Corteva is inevitable lol.

[northwick] 25/1/2021 16:50

SuperNice to see your other favourite a 'See.l'company is up 10% on the day. Has proven to be a better investment than Eden so far but hopefully not for long.

[alchemy] 25/1/2021 09:30

Ok continuing my reacquaintance with things. Corteva trial announced 8/1/20 . So does each day make the result more likely ?yes. A positive one? Eden says results in line with expectations thus far in earlier RNS. So likelihood is not reducing as expected year long trial lengthens beyond a year?I'm fishing! ....atb.

[investingisatrickygame] 25/1/2021 09:16

15th April 2020 RNS - Appointment of Director of Regulatory Affairs

"CEO Sean Smith commented: "Mike is a key appointment that further demonstrates our focus on building a high-calibre team around the core functions within our business. He brings significant capabilities to the Company in the critical areas of product registration and regulatory compliance. Mike has a wealth of international experience which has given him invaluable expertise in product registration globally. Mike comes with a long track record of driving successful regulatory outcomes in the crop protection industry, a network of key industry influencers, and experience in senior roles at industry leaders such as Dow AgroSciences and Monsanto. We are pleased to welcome him to Eden."

FOOD FOR THOUGHT 3rd June 2020 Meeting Dr Mike Carroll

"What does your role at Eden entail?
My role is about managing the approvals that we have and moving ahead with new registrations all over the world thereby increasing the ‘footprintR17; that we have which allows us to subsequently grow sales"

AND

"What do you hope to achieve over the next year at Eden?
I hope to help progress many of the pending authorisations we have in our pipeline. One of the big projects to note is the Mevalone and Cedroz authorisations in the United States. We are in the last stages of the federal authorisation which will allow states to give their own authorisations. We are currently actively working with EPA to answer their questions, and we are hoping to get a decision as soon as possible, ideally by the end of the year."

Surely Eden owes the market an update on pending registrations. The Placing RNS of the 20th February 2020 was the last indication we had which was noted in the Appendix and that simply stated 'submitted and pending'


Couldn't Dr Mike Carroll do a piece to film introducing himself and updating us all on progress OR the Company simply do an update RNS as they did with the Bayer agreement last year. This seems totally reasonable to me for the market to expect this and also based on time lapsed.

[investingisatrickygame] 25/1/2021 09:07

Eden Market Opportunities

€330 Million Cedroz and Mevalone from the Placing RNS Approved and Approvals
pending
€ 40 Million Corteva seeds as RNS'd
€ TBC Corteva additional opportunities being explored (AGM Q & A)
€ TBC Seeds in partnership (AGM Q & A)
€ TBC Seeds alone (AGM Q & A)
€ 85 Million Insecticide (US & EUROPE) From the Placing RNS and AGM Q & A - 5-10%.
Are the remaining safety and efficacy trials nearly finished?

This post is not formatting properly, but basically, Eden has defined existing and near market opportunities as €455 million p.a. not including those values which are yet to be confirmed, although we might reasonably consider Eden is advanced in the development of these new market opportunities from Eden's own commentary.

[brucie5] 24/1/2021 15:49

Investingisatrickygame24 Jan '21 - 15:12 - 8728 of 8728
0 0 0
@Brucie

I'm going to wild guess that if Corteva is positive, so too will the other seed company developments
----------------------------------------------------------------
That, surely, is part of the same binary play.
I am optimistic, but whereas I once held 1m shares and lived to regret it, my holding now is more proportionate to the risk of disappointment - and EDEN has always disappointed.
However, ITM disappointed for many years. I think that even given a positive, company making announcement, there will be opportunities to get on board before the greater uplift, which may see it to multiples.

[investingisatrickygame] 24/1/2021 15:12

@Brucie

And yet the Company tells us that there are other seed company trials and discussions in play and Edens own Insecticides too.

I'm going to wild guess that if Corteva is positive, so too will the other seed company developments

[alchemy] 24/1/2021 14:51

Thanks , yes binary referred to Corteva , thanks for observations. Makes BBs worthwhile.

[brucie5] 24/1/2021 14:41

Investingisatrickygame24 Jan '21 - 14:24 - 8725 of 8725
0 0 0
@Alchemy

"The upside of the binary opportunity seems huge."
---------------------------------------------------
Well yes and no: without a game changing announcement on Corteva, of which I am hopeful, the sales growth via VED/MEV is unlikely to set the share price on fire. That has been the consistent story of disappointed hopes thus far. Even with positive news from the US, there will be no immediate impact on sales for some time. I think this was Wan's broader point, when he left.

So for me, it's pretty binary.

[investingisatrickygame] 24/1/2021 14:24

@Alchemy

"The upside of the binary opportunity seems huge."

I'm not sure if you are referring to the Corteva deal or Eden. IF the former, then correct. If the latter, Eden is anything but a binary opportunity and should see this calendar year, many more (in my opinion) new income streams announced.

This is in addition to Corteva and the €323 million opportunity that is Cedroz and Mevalone, as detailed in last years Placing RNS.

[alchemy] 24/1/2021 13:04

I've been focused on VRS but have been conscious of this company for some time. The upside of the binary opportunity seems huge . I find a toe in the water always enhances my fact finding.It won't move the market . See you tomorrow.

[supersonico] 23/1/2021 16:27

Thanks Investing.

I'm trying to find the SustainE logo on Justia..can't find it or anything related to Eden.

Why would it not be there?

[investingisatrickygame] 23/1/2021 15:47

@Super

Not much use, but the UK gov website just shows ownership of two, being Mevalone and Sustaine

[attyg] 23/1/2021 09:53

When Northwick wrote in his 8676 post that one of his contacts, with whom he regularly talks, suggested the share price could pass £2 on the Corteva news alone, I, and I am sure most readers, thought that fanciful.
However, if one takes the BoD statement from the Interim Presentation:


Opportunity for up to €40 million of revenue in a limited number
of geographies, with significant upside potential.

The figure of €40 million revenue has been mentioned on a number of occasions - with NOMAD approval.
As has the statement from the BoD that there is significant upside potential with Corteva.
Well, there has to be, hasn't there?
The evaluation agreement covers a few territories and for a limited number of crops and Cenkos noted that Corteva generated ~$14bn revenue from its Seed and Crop protection business and that their seed business is second only to Bayer.
So plenty upside.
Also plenty "delay" in concluding the deal between Eden and Corteva!
So, let's just say the eventual deal has scope to generate £100m of revenues to Eden with a GP of 40% (in line with the GP margins mentioned throughout by Cenkos).
Assume Eden's other products cover all the admin costs, thus the GP drops to the bottom line.
PBT of £40m with a PE of 10 gives Eden a share price of £1
PBT of £40m with a PE of 20 gives Eden a share price of £2
With a fast growing company with loads more potential than just a few sales to Corteva, a PE of more like 30 will be applicable.

I acknowledge life is not so simple and there are many other factors at play, however, sometimes keeping it simple is helpful.

So, we may need to leave a bit of space for that Harrier Jump jet.

[supersonico] 23/1/2021 09:03

Can Anyone recommend a data base that shows Eden's Trademarks? SustainE / Mevalone etc

[supersonico] 22/1/2021 16:11

Northwick,

Loads more to come.

[northwick] 22/1/2021 16:02

SuperYou must be pleased to see your other other favourite co- See - trading over 10p. More to come?Your opinion and view is always welcomed.

[fracman2] 22/1/2021 15:59

Thanks Northwick

[northwick] 22/1/2021 14:56

FracmanFrom where I am sitting, there is no other Company in the UK that is close to offering what Eden has to. It has a lot of good technology to offer. Admitted, it takes a long time to prove and deliver on this. We all now know that Corteva has had two years of field trials, and they have not report any negative results as otherwise Eden would be duty bound to inform the market. To the contrary, Eden has confirmed in its 1/2 yearly presentation that ' results to date are in-line with expectations' No nomad would allow such a statement to be put out if they weren't assured.So, like I said earlier, if I had time on my side, I would be happy to add without any hesitation.Please do your own research before investing.

[fracman2] 22/1/2021 13:56

I really hope we get positive news Northwick. As a previous poster mentioned if it was bad news they could have told us in minutes.
It seems the share price is effected a lot on small trades so hopefully no drama.

[northwick] 22/1/2021 12:48

To me, almost all of today's trades are buys as MM are offering shares at 12.15p in small size. I know of a couple of buys that have't been printed yet. So not all is gloom & doom. Not long to go before we hear from Eden on Corteva.